Literature DB >> 12722176

Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease.

Eng-King Tan1, Yanni Tan, Anthea Chai, Christopher Tan, Hui Shen, Sau-Ying Lum, Stephanie M C Fook-Cheong, Mei-Ling Teoh, Yuan Yih, Meng-Cheong Wong, Yi Zhao.   

Abstract

In a case control study, we examined the association of DRD2 Taq1A and Taq1B polymorphisms and risk of PD, and evaluated the strength of linkage disequilibrium of the polymorphisms. The Taq1A and Taq1B polymorphisms were in strong linkage disequilibrium. There was, however, no significant association of the two polymorphisms with PD. Copyright 2003 Movement Disorder Society

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12722176     DOI： 10.1002/mds.10406

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  15 in total

1.  An association study on the polymorphisms of dopaminergic genes with working memory in a healthy Chinese Han population.

Authors:  Pingyuan Gong; Hang Zhang; Wanyu Chi; Wanhua Ge; Kejin Zhang; Anyun Zheng; Xiaocai Gao; Fuchang Zhang
Journal:  Cell Mol Neurobiol       Date:  2012-02-24       Impact factor: 5.046

2.  Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.

Authors:  Anhar Hassan; Michael G Heckman; J E Ahlskog; Zbigniew K Wszolek; Daniel J Serie; Ryan J Uitti; Jay A van Gerpen; Michael S Okun; Sruti Rayaprolu; Owen A Ross
Journal:  Parkinsonism Relat Disord       Date:  2015-11-25       Impact factor: 4.891

3.  Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker.

Authors:  Ramesh C Juyal; Mitashree Das; Sohan Punia; Madhuri Behari; Geetika Nainwal; Sumit Singh; Pazhayannur V Swaminath; Shyla T Govindappa; Sachi Jayaram; Uday B Muthane; B K Thelma
Journal:  Neurogenetics       Date:  2006-07-01       Impact factor: 2.660

4.  Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms.

Authors:  Cüneyt Güzey; Maria Gabriella Scordo; Edoardo Spina; Veslemøy Malm Landsem; Olav Spigset
Journal:  Eur J Clin Pharmacol       Date:  2007-01-17       Impact factor: 2.953

5.  Association of dopamine receptor gene polymorphisms with the clinical course of Wilson disease.

Authors:  T Litwin; G Gromadzka; J Samochowiec; A Grzywacz; A Członkowski; A Członkowska
Journal:  JIMD Rep       Date:  2012-07-06

6.  Comparative analysis of four disease prediction models of Parkinson's disease.

Authors:  Nadella Kumudini; Shaik Mohammad Naushad; Balraj Alex Stanley; Manoharan Niveditha; Gunasekaran Sharmila; Konda Kumaraswami; Rupam Borghain; Rukmini Mridula; Vijay Kumar Kutala
Journal:  Mol Cell Biochem       Date:  2015-10-05       Impact factor: 3.396

7.  Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.

Authors:  V McGuire; S K Van Den Eeden; C M Tanner; F Kamel; D M Umbach; K Marder; R Mayeux; B Ritz; G W Ross; H Petrovitch; B Topol; R A Popat; S Costello; A D Manthripragada; A Southwick; R M Myers; L M Nelson
Journal:  J Neurol Sci       Date:  2011-06-12       Impact factor: 3.181

Review 8.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

9.  Genetic susceptibility in solvent induced neurobehavioral effects.

Authors:  L Godderis; N Maertens; V de Gelder; A De Lamper; K De Ruyck; M Vernimmen; S Bulterys; G Moens; H Thierens; M K Viaene
Journal:  Neurotox Res       Date:  2009-08-22       Impact factor: 3.911

10.  Polymorphism in environment responsive genes and association with Parkinson disease.

Authors:  Madhu Singh; Anwar J Khan; Parag P Shah; Rakesh Shukla; V K Khanna; Devendra Parmar
Journal:  Mol Cell Biochem       Date:  2008-03-09       Impact factor: 3.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.